Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa: implications for the future

Brian Godman, Debashis Basu, Yogan Pillay, Paulo H. R. F. Almeida, Julius C. Mwita, Godfrey Mutashambara Rwegerera, Bene D Anand Paramadhas, Celda Tiroyakgosi, Okwen Patrick, Loveline Lum Niba, Israel Sefah, Margaret Oluka, Anastasia Guantai, Dan Kibuule, Francis Kalemeera, Mwangana Mubita, Joseph Fadare, Olayinka O. Ogunleye, Enos M Rampamba, Jeffrey WingDebjani Mueller, Abubakr Alfadl, Adefolarin A Amu, Zinhle Matsebula, Aubrey Kalungia, Trust Zaranyika, Nyasha Masuka, Janney Wale, Ruaraidh Hill, Amanj Kurdi, Angela Timoney, Stephen Campbell, Johanna C Meyer

Research output: Contribution to journalArticle

Abstract

Background: Currently about 19 million people in Africa are known to be living diabetes, mainly Type 2 diabetes (T2DM) (95%), estimated to grow to 47 million people by 2045. However, there are concerns with early diagnosis of patients with Type 1 diabetes (T1DM) as often patients present late with complications. There are also challenges with access and affordability of insulin, monitoring equipment and test strips with typically high patient co-payments, which can be catastrophic for families. These challenges negatively impact on the quality of care of patients with T1DM increasing morbidity and mortality. There are also issues of patient education and psychosocial support adversely affecting patients’ quality of life. These challenges need to be debated and potential future activities discussed to improve the future care of patients with T1DM across Africa. Methodology: Documentation of the current situation across Africa for patients with T1DM including the epidemiology, economics, and available treatments within public healthcare systems as well as ongoing activities to improve their future care. Subsequently, provide guidance to all key stakeholder groups going forward utilising input from senior level government, academic and other professionals from across Africa. Results: Whilst prevalence rates for T1DM are considerably lower than T2DM, there are concerns with late diagnosis as well as the routine provision of insulin and monitoring equipment across Africa. High patient co-payments exacerbate the situation. However, there are ongoing developments to address the multiple challenges including the instigation of universal health care and partnerships with non-governmental organisations, patient organisations and pharmaceutical companies. Their impact though remains to be seen. A range of activities have been documented for all key stakeholder groups to improve future care. Conclusion: There are concerns with the management of patients with T1DM across Africa. A number of activities have been suggested to address this and will be monitored.
Original languageEnglish
Number of pages28
JournalHospital Practice
Early online date13 May 2020
DOIs
Publication statusE-pub ahead of print - 13 May 2020

    Fingerprint

Keywords

  • diabetes
  • Africa
  • African healthcare system

Cite this